Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- Nucala (mepolizumab) is the first treatment to show a significant reduction in flares for patients with Hypereosinophilic Syndrome (HES)
- EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV
- GSK delivers sales of £9.4 billion +16% AER, +11% CER (Pro-forma +6% CER*)
Tweets from GSK
-
GSK @GSK
Today is 🌏 World COPD Day. Hear from caregivers and healthcare professionals on how we can help people living with COPD.#LiveEveryBreathh#AllTogetherro
about 1 day ago -
GSK @GSK
Today, scientists, investors and entrepreneurs – all leading #womeninscience – gather for #biobeat19 to discuss how the UK can continue to foster breakthroughs for patients like cell and gene therapy. Stay tuned for updates…
about 1 day ago
-
GSK @GSK
Very proud to announce Rino Rappuoli has received the 2019 Robert Koch Award to recognise his ground-breaking work on the development of novel vaccines. Well done Rino! gsk.to/2qhzoSx
about 1 day ago
